Cancer epidemiology in high-risk populations and complex cancers.

My research program aims to better understand the causes of cancer and factors that influence outcomes after cancer diagnosis. It employs classical and innovative cancer epidemiology and includes large-scale studies of cancer incidence, survival and risk factors in people with immune dysfunction. It also includes studies of lymphoid malignancies and `cancer of unknown primary' origin. The research program aims to build an evidence base for interventions that will reduce the burden of cancer nationally and internationally.